Four cases of pancreatic fistula were treated with somatostatin. Two c
ases occurred after caudal pancreatectomy and the other 2 after duoden
opancreatectomy. Somatostatin rapidly reduced fistula flow by 50% 48 h
ours after treatment. The shorter hospital stay and reduced morbidity
underline the importance of somatostatin in the treatment of pancreati
c fistulae.